QuantLogix Investor Profile

← Back to investors

Lux Capital Bio

Lux Capital's bio practice
VC Sector Specialist 📍 New York, NY Founded 2014
AUM
$1.5B
as of 2026-Q1
SMALL
Lux Capital Bio is the dedicated bio practice within Lux Capital, focused on synthetic biology, computational drug discovery, and bio-platform companies.

Firm Profile

Firm Type
VC
Subtype
Sector Specialist
Founded
2014
HQ
New York, NY
Country
USA

Notable Partners

Adam GoulburnZavain Dar

Notable Portfolio

recursiondesktop-metal

Investment Focus

Stages
Series A · Series B
Sectors
Bio · Synthetic Biology
VCBio SpecialistLux Family
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of 2026-Q1. Refreshed periodically.